Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 5 Unknown 2 Terminated 2 Withdrawn 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other 1 Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Fluorouracil 51 Oxaliplatin 49 Gemcitabine 47 Leucovorin 41 Capecitabine 35 Bevacizumab 29 Irinotecan 25 Cisplatin 22 Radiotherapy 18 Radiosurgery 18 pembrolizumab 16 Nivolumab 16 Cetuximab 15 Taxes 14 Sorafenib 14 Paclitaxel 13 Biopsy 13 Surgical Procedures, Operative 12 Drug Therapy 11 atezolizumab 10 Radiation 10 Albumin-Bound Paclitaxel 10 lenvatinib 9 durvalumab 9 Magnetic Resonance Spectroscopy 9 Folfox protocol 9 Cyclophosphamide 9 130-nm albumin-bound paclitaxel 9 spartalizumab 8 Chemotherapy, Adjuvant 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Losartan × Gastrointestinal × Clear all

NCT05861336 2024-12-27

OVERPASS

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Phase 2 Withdrawn

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡